This portal offers free access to accredited Continuing Medical Education (CME/CE) programs. These educational activities are updated regularly and provide online certification. Opportunities for CME/CE credit include symposia, newsletters, slide presentations, monographs, and case studies. Registration and login are required only to obtain CME/CE credit.

Psoriatic arthritis is an inflammatory joint condition that in some patients follows the development of psoriasis. Because of the association between these two conditions, the dermatologist plays a crucial role in the diagnosis, and often the management of, psoriatic arthritis. In this Expert Practice, Dr. Kenneth Gordon of the University of Chicago Pritzker School of Medicine and the NorthShore University HealthSystem discusses how dermatologists should approach the diagnosis and management of psoriatic arthritis. The role of the rheumatologist in the care of patients with psoriatic arthritis is also addressed.

This activity has been approved for 1.75 AMA PRA Category 1 Credits^TM.
VIEW ACTIVITY    Available at PsoriasisTx.com

A major focus in the management of rheumatoid arthritis is on early diagnosis and intervention. It is clear that early aggressive therapy results in better outcomes for patients with progressive rheumatoid arthritis. Identification of patients who are most likely to have advancing disease is important because rapid and intensive intervention offers the potential to change the course of disease. This activity includes case-based scenarios to illustrate management strategies for patients with rheumatoid arthritis.

This activity has been approved for 1.75 AMA PRA Category 1 Credits^TM.
VIEW ACTIVITY     REQUEST CD-ROM

A 42-year-old woman who was diagnosed with rheumatoid arthritis 4 months earlier presents to your virtual office for a follow-up visit, and you—in consultation with Eric Ruderman, MD, of Northwestern University—are reassessing her treatment regimen because of continued high disease activity. "Consult" with Dr. Ruderman and your peers as you manage this challenging case with the goal of achieving remission.

This activity has been approved for 0.75 AMA PRA Category 1 Credits^TM.
View Article

Intensive management, or tight control, of rheumatoid arthritis (RA) has been shown to be associated with better patient outcomes. For this issue of Expert Practice, we interviewed Philip Mease, MD, Chief of Rheumatology Research at the Swedish Medical Center and Clinical Professor of Medicine at the University of Washington in Seattle, Washington. He provided insights regarding the benefits of maintaining tight control in the treatment of RA as well as tips on how to quantify disease activity.

This activity has been approved for 0.5 AMA PRA Category 1 Credits^TM.
View Article

In June 2008, the American College of Rheumatology (ACR) issued updated recommendations for using disease-modifying antirheumatic drugs (DMARDs) in the treatment of patients with rheumatoid arthritis (RA). The recommendations, which had not been updated since 2003, include biologic agents in their scope for the first time. Developed to reflect current standards in the management of RA, the updated recommendations include treatment algorithms based on accumulated scientific evidence. In this Expert Practice article, Dr. Kenneth G. Saag, a member of the Task Force Panel and lead author of the updated ACR recommendations, discusses the new recommendations, describing the role of disease activity assessment, safety monitoring, contraindications, and the use of specific agents in the management of RA.

This activity has been approved for 0.5 AMA PRA Category 1 Credits^TM.
View Article

Cardiovascular disease (CVD) is a significant source of morbidity and mortality in the United States. Inflammatory conditions such as rheumatoid arthritis (RA) are associated with an increased risk for cardiovascular disease. In this Expert Practice Arthur Kavanaugh, MD, discusses the impact of cardiovascular risk factors on the management of patients with RA. Topics addressed include epidemiology of CVD and related risk factors in patients with rheumatoid arthritis, how rheumatoid arthritis treatment influences cardiovascular risk factors, and the overall management of rheumatoid arthritis patients with cardiovascular risk factors.

Sponsored by Curatio CME Institute

This activity has been approved for 0.5 AMA PRA Category 1 Credits^TM.
View Article